397 related articles for article (PubMed ID: 24293330)
1. Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.
Sandri M; Coletto L; Grumati P; Bonaldo P
J Cell Sci; 2013 Dec; 126(Pt 23):5325-33. PubMed ID: 24293330
[TBL] [Abstract][Full Text] [Related]
2. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
Sandri M
Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms of muscle atrophy.
Bonaldo P; Sandri M
Dis Model Mech; 2013 Jan; 6(1):25-39. PubMed ID: 23268536
[TBL] [Abstract][Full Text] [Related]
4. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling.
Laure L; Suel L; Roudaut C; Bourg N; Ouali A; Bartoli M; Richard I; Danièle N
FEBS J; 2009 Feb; 276(3):669-84. PubMed ID: 19143834
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of skeletal muscle atrophy.
Ventadour S; Attaix D
Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy.
Sandri M
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1291-7. PubMed ID: 20089936
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders.
Kitajima Y; Yoshioka K; Suzuki N
J Physiol Sci; 2020 Sep; 70(1):40. PubMed ID: 32938372
[TBL] [Abstract][Full Text] [Related]
8. Dynamics and Interplay between Autophagy and Ubiquitin-proteasome system Coordination in Skeletal Muscle Atrophy.
Singh A; Yadav A; Phogat J; Dabur R
Curr Mol Pharmacol; 2022; 15(3):475-486. PubMed ID: 34365963
[TBL] [Abstract][Full Text] [Related]
9. TRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle.
Paul PK; Kumar A
Autophagy; 2011 May; 7(5):555-6. PubMed ID: 21412053
[TBL] [Abstract][Full Text] [Related]
10. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy.
Milan G; Romanello V; Pescatore F; Armani A; Paik JH; Frasson L; Seydel A; Zhao J; Abraham R; Goldberg AL; Blaauw B; DePinho RA; Sandri M
Nat Commun; 2015 Apr; 6():6670. PubMed ID: 25858807
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.
Doyle A; Zhang G; Abdel Fattah EA; Eissa NT; Li YP
FASEB J; 2011 Jan; 25(1):99-110. PubMed ID: 20826541
[TBL] [Abstract][Full Text] [Related]
12. Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Ringseis R; Keller J; Lukas I; Spielmann J; Most E; Couturier A; König B; Hirche F; Stangl GI; Wen G; Eder K
Biochim Biophys Acta; 2013 Jan; 1830(1):2105-17. PubMed ID: 23041501
[TBL] [Abstract][Full Text] [Related]
13. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modifications control FoxO3 activity during denervation.
Bertaggia E; Coletto L; Sandri M
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
[TBL] [Abstract][Full Text] [Related]
15. Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.
Cid-Díaz T; Santos-Zas I; González-Sánchez J; Gurriarán-Rodríguez U; Mosteiro CS; Casabiell X; García-Caballero T; Mouly V; Pazos Y; Camiña JP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):974-990. PubMed ID: 28675664
[TBL] [Abstract][Full Text] [Related]
16. Proteasome expression in the skeletal muscles of patients with muscular dystrophy.
Kumamoto T; Fujimoto S; Ito T; Horinouchi H; Ueyama H; Tsuda T
Acta Neuropathol; 2000 Dec; 100(6):595-602. PubMed ID: 11078210
[TBL] [Abstract][Full Text] [Related]
17. FoxO3 controls autophagy in skeletal muscle in vivo.
Mammucari C; Milan G; Romanello V; Masiero E; Rudolf R; Del Piccolo P; Burden SJ; Di Lisi R; Sandri C; Zhao J; Goldberg AL; Schiaffino S; Sandri M
Cell Metab; 2007 Dec; 6(6):458-71. PubMed ID: 18054315
[TBL] [Abstract][Full Text] [Related]
18. Ca(2+)-dependent proteolysis in muscle wasting.
Costelli P; Reffo P; Penna F; Autelli R; Bonelli G; Baccino FM
Int J Biochem Cell Biol; 2005 Oct; 37(10):2134-46. PubMed ID: 15893952
[TBL] [Abstract][Full Text] [Related]
19. P38α MAPK coordinates the activities of several metabolic pathways that together induce atrophy of denervated muscles.
Odeh M; Tamir-Livne Y; Haas T; Bengal E
FEBS J; 2020 Jan; 287(1):73-93. PubMed ID: 31545558
[TBL] [Abstract][Full Text] [Related]
20. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
Zhao J; Brault JJ; Schild A; Cao P; Sandri M; Schiaffino S; Lecker SH; Goldberg AL
Cell Metab; 2007 Dec; 6(6):472-83. PubMed ID: 18054316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
